Loading…

Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA ind...

Full description

Saved in:
Bibliographic Details
Published in:The European journal of neuroscience 2000-06, Vol.12 (6), p.2117-2123
Main Authors: Bordet, Régis, Ridray, Sophie, Schwartz, Jean-Charles, Sokoloff, Pierre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13
cites cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13
container_end_page 2123
container_issue 6
container_start_page 2117
container_title The European journal of neuroscience
container_volume 12
creator Bordet, Régis
Ridray, Sophie
Schwartz, Jean-Charles
Sokoloff, Pierre
description Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.
doi_str_mv 10.1046/j.1460-9568.2000.00089.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20952990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20952990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</originalsourceid><addsrcrecordid>eNqNkctu1DAYRi0EokPhFVDEArFJsOP4JrFBozIUlcKiCMTGchKH8ZDYU9uZTnh6nKaqEAvEwvLiP9_nywEgQ7BAsKKvdwWqKMwFobwoIYRFWlwUxwdgdT94CFZQEJxzRL-dgCch7GaIVuQxOEGQc4oJWoF4bg-uP-hB25i5LotbnbXG6yZmIXqjorPmh1d9tldxe6OmzNis1wfXur3KjW3HRrdZ0DaYaH6paJydCZpvp9a74zRjg7E673VIs8R6FcNT8KhTfdDP7vZT8OXd2dX6fX7xaXO-fnuRN4QIkWOOddV0DCFUNko0tGsIhryuy1IxRrVQuBKK6bqqBSlbSOs6Bbqa4E7hukP4FLxcevfeXY86RDmY0Oi-V1a7McgyfVApBEzgq3-CiHFIEBNcJPTFX-jOjd6mZ6S6quSoYvPBfIEa70LwupN7bwblJ4mgnA3KnZxFyVmUnA3KW4PymKLP7_rHetDtH8FFWQLeLMCN6fX038Xy7MMlvL1_vsRNiPp4H1f-p6QMMyK_Xm7kR7S5-sy-C7nGvwGjxLsN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204281471</pqid></control><display><type>article</type><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</creator><creatorcontrib>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</creatorcontrib><description>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</description><identifier>ISSN: 0953-816X</identifier><identifier>EISSN: 1460-9568</identifier><identifier>DOI: 10.1046/j.1460-9568.2000.00089.x</identifier><identifier>PMID: 10886351</identifier><identifier>CODEN: EJONEI</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Animals ; Antiparkinson Agents - pharmacology ; Benzazepines - metabolism ; Benzazepines - pharmacology ; Binding, Competitive - physiology ; Corpus Striatum - cytology ; Denervation ; Dizocilpine Maleate - pharmacology ; Dopamine Agonists - metabolism ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - metabolism ; Dopamine Antagonists - pharmacology ; dopamine D3 receptor ; Enkephalins - genetics ; Excitatory Amino Acid Antagonists - pharmacology ; Gene Expression - physiology ; Levodopa - pharmacology ; Male ; Neural Pathways ; Neurons - chemistry ; Neurons - physiology ; Opioid Peptides - metabolism ; Oxidopamine ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - drug therapy ; Parkinson Disease, Secondary - pathology ; Parkinson's disease ; preprotachykinin ; prodynorphin ; Protein Precursors - genetics ; Rats ; Rats, Wistar ; Receptors, Dopamine D2 - analysis ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D3 ; RNA, Messenger - analysis ; Substantia Nigra - cytology ; Sympatholytics ; Tachykinins - genetics ; Tetrahydronaphthalenes - metabolism ; Tetrahydronaphthalenes - pharmacology ; Tritium ; Ventral Tegmental Area - cytology</subject><ispartof>The European journal of neuroscience, 2000-06, Vol.12 (6), p.2117-2123</ispartof><rights>European Neuroscience Association</rights><rights>Copyright Oxford University Press Jun 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</citedby><cites>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10886351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bordet, Régis</creatorcontrib><creatorcontrib>Ridray, Sophie</creatorcontrib><creatorcontrib>Schwartz, Jean-Charles</creatorcontrib><creatorcontrib>Sokoloff, Pierre</creatorcontrib><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><title>The European journal of neuroscience</title><addtitle>Eur J Neurosci</addtitle><description>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</description><subject>Animals</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Benzazepines - metabolism</subject><subject>Benzazepines - pharmacology</subject><subject>Binding, Competitive - physiology</subject><subject>Corpus Striatum - cytology</subject><subject>Denervation</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Dopamine Agonists - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - metabolism</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>dopamine D3 receptor</subject><subject>Enkephalins - genetics</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Gene Expression - physiology</subject><subject>Levodopa - pharmacology</subject><subject>Male</subject><subject>Neural Pathways</subject><subject>Neurons - chemistry</subject><subject>Neurons - physiology</subject><subject>Opioid Peptides - metabolism</subject><subject>Oxidopamine</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - drug therapy</subject><subject>Parkinson Disease, Secondary - pathology</subject><subject>Parkinson's disease</subject><subject>preprotachykinin</subject><subject>prodynorphin</subject><subject>Protein Precursors - genetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Dopamine D2 - analysis</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D3</subject><subject>RNA, Messenger - analysis</subject><subject>Substantia Nigra - cytology</subject><subject>Sympatholytics</subject><subject>Tachykinins - genetics</subject><subject>Tetrahydronaphthalenes - metabolism</subject><subject>Tetrahydronaphthalenes - pharmacology</subject><subject>Tritium</subject><subject>Ventral Tegmental Area - cytology</subject><issn>0953-816X</issn><issn>1460-9568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1DAYRi0EokPhFVDEArFJsOP4JrFBozIUlcKiCMTGchKH8ZDYU9uZTnh6nKaqEAvEwvLiP9_nywEgQ7BAsKKvdwWqKMwFobwoIYRFWlwUxwdgdT94CFZQEJxzRL-dgCch7GaIVuQxOEGQc4oJWoF4bg-uP-hB25i5LotbnbXG6yZmIXqjorPmh1d9tldxe6OmzNis1wfXur3KjW3HRrdZ0DaYaH6paJydCZpvp9a74zRjg7E673VIs8R6FcNT8KhTfdDP7vZT8OXd2dX6fX7xaXO-fnuRN4QIkWOOddV0DCFUNko0tGsIhryuy1IxRrVQuBKK6bqqBSlbSOs6Bbqa4E7hukP4FLxcevfeXY86RDmY0Oi-V1a7McgyfVApBEzgq3-CiHFIEBNcJPTFX-jOjd6mZ6S6quSoYvPBfIEa70LwupN7bwblJ4mgnA3KnZxFyVmUnA3KW4PymKLP7_rHetDtH8FFWQLeLMCN6fX038Xy7MMlvL1_vsRNiPp4H1f-p6QMMyK_Xm7kR7S5-sy-C7nGvwGjxLsN</recordid><startdate>200006</startdate><enddate>200006</enddate><creator>Bordet, Régis</creator><creator>Ridray, Sophie</creator><creator>Schwartz, Jean-Charles</creator><creator>Sokoloff, Pierre</creator><general>Blackwell Science Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200006</creationdate><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><author>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Benzazepines - metabolism</topic><topic>Benzazepines - pharmacology</topic><topic>Binding, Competitive - physiology</topic><topic>Corpus Striatum - cytology</topic><topic>Denervation</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Dopamine Agonists - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - metabolism</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>dopamine D3 receptor</topic><topic>Enkephalins - genetics</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Gene Expression - physiology</topic><topic>Levodopa - pharmacology</topic><topic>Male</topic><topic>Neural Pathways</topic><topic>Neurons - chemistry</topic><topic>Neurons - physiology</topic><topic>Opioid Peptides - metabolism</topic><topic>Oxidopamine</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - drug therapy</topic><topic>Parkinson Disease, Secondary - pathology</topic><topic>Parkinson's disease</topic><topic>preprotachykinin</topic><topic>prodynorphin</topic><topic>Protein Precursors - genetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Dopamine D2 - analysis</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D3</topic><topic>RNA, Messenger - analysis</topic><topic>Substantia Nigra - cytology</topic><topic>Sympatholytics</topic><topic>Tachykinins - genetics</topic><topic>Tetrahydronaphthalenes - metabolism</topic><topic>Tetrahydronaphthalenes - pharmacology</topic><topic>Tritium</topic><topic>Ventral Tegmental Area - cytology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bordet, Régis</creatorcontrib><creatorcontrib>Ridray, Sophie</creatorcontrib><creatorcontrib>Schwartz, Jean-Charles</creatorcontrib><creatorcontrib>Sokoloff, Pierre</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The European journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bordet, Régis</au><au>Ridray, Sophie</au><au>Schwartz, Jean-Charles</au><au>Sokoloff, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</atitle><jtitle>The European journal of neuroscience</jtitle><addtitle>Eur J Neurosci</addtitle><date>2000-06</date><risdate>2000</risdate><volume>12</volume><issue>6</issue><spage>2117</spage><epage>2123</epage><pages>2117-2123</pages><issn>0953-816X</issn><eissn>1460-9568</eissn><coden>EJONEI</coden><abstract>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10886351</pmid><doi>10.1046/j.1460-9568.2000.00089.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0953-816X
ispartof The European journal of neuroscience, 2000-06, Vol.12 (6), p.2117-2123
issn 0953-816X
1460-9568
language eng
recordid cdi_proquest_miscellaneous_20952990
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Antiparkinson Agents - pharmacology
Benzazepines - metabolism
Benzazepines - pharmacology
Binding, Competitive - physiology
Corpus Striatum - cytology
Denervation
Dizocilpine Maleate - pharmacology
Dopamine Agonists - metabolism
Dopamine Agonists - pharmacology
Dopamine Antagonists - metabolism
Dopamine Antagonists - pharmacology
dopamine D3 receptor
Enkephalins - genetics
Excitatory Amino Acid Antagonists - pharmacology
Gene Expression - physiology
Levodopa - pharmacology
Male
Neural Pathways
Neurons - chemistry
Neurons - physiology
Opioid Peptides - metabolism
Oxidopamine
Parkinson Disease, Secondary - chemically induced
Parkinson Disease, Secondary - drug therapy
Parkinson Disease, Secondary - pathology
Parkinson's disease
preprotachykinin
prodynorphin
Protein Precursors - genetics
Rats
Rats, Wistar
Receptors, Dopamine D2 - analysis
Receptors, Dopamine D2 - genetics
Receptors, Dopamine D3
RNA, Messenger - analysis
Substantia Nigra - cytology
Sympatholytics
Tachykinins - genetics
Tetrahydronaphthalenes - metabolism
Tetrahydronaphthalenes - pharmacology
Tritium
Ventral Tegmental Area - cytology
title Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A29%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20the%20direct%20striatonigral%20pathway%20in%20levodopa-induced%20sensitization%20in%206-hydroxydopamine-lesioned%20rats&rft.jtitle=The%20European%20journal%20of%20neuroscience&rft.au=Bordet,%20R%C3%A9gis&rft.date=2000-06&rft.volume=12&rft.issue=6&rft.spage=2117&rft.epage=2123&rft.pages=2117-2123&rft.issn=0953-816X&rft.eissn=1460-9568&rft.coden=EJONEI&rft_id=info:doi/10.1046/j.1460-9568.2000.00089.x&rft_dat=%3Cproquest_cross%3E20952990%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=204281471&rft_id=info:pmid/10886351&rfr_iscdi=true